Delapane, Ana Y.
HRN: 23-27-76 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/08/2023
CEFUROXIME 1.5GM (VIAL)
09/08/2023
09/09/2023
IV
1.5
Q8
Cs
Waiting Final Action
09/08/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/08/2023
09/09/2023
IV
500
Q8
Cs
Waiting Final Action
09/09/2023
CEFUROXIME 500MG (TAB)
09/09/2023
09/15/2023
PO
500mg
BID
CS
Waiting Final Action
09/09/2023
CEFUROXIME 500MG (TAB)
09/09/2023
09/15/2023
PO
500mg
BID
CS
Waiting Final Action
09/09/2023
METRONIDAZOLE 500MG (TAB)
09/09/2023
09/15/2023
PO
500
TID
Cs
Waiting Final Action